SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-212572
Filing Date
2018-07-05
Accepted
2018-07-03 17:42:35
Documents
3
Group Members
FHM LIFE SCIENCES VIII, L.L.C.FHM LIFE SCIENCES VIII, L.P.JAMES N. TOPPERPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 SC 13D d649710dsc13d.htm SC 13D 116406
2 EX-99.A d649710dex99a.htm EX-99.A 7803
3 EX-99.B d649710dex99b.htm EX-99.B 22447
  Complete submission text file 0001193125-18-212572.txt   148313
Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Life Sciences VIII, L.P. (Filed by) CIK: 0001655827 (see all company filings)

IRS No.: 475290848 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Subject) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90542 | Film No.: 18938680
SIC: 2834 Pharmaceutical Preparations